Legal & Licensing
361 - 375 of
516 Results
Sort Results:
Article:
A new Risk Evaluation and Mitigation Strategy (REMS) will aim to reduce the misuse of long-acting opioids
June 2011
Article:
new risk management programs with Abstral (AB-stral) and other immediate-release fentanyl products
May 2011
Article:
About 500 Rx cough, cold, and allergy products will be taken off the market by September
April 2011
Article:
whether patients on stimulants for ADHD can take cough, cold, and allergy meds containing decongestants
April 2011
Guideline:
Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (April 2008)
April 2011